HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Q Wu Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

10/2017Deferoxamine-activated hypoxia-inducible factor-1 restores cardioprotective effects of sevoflurane postconditioning in diabetic rats.
3/2013KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF.
10/2005Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Q Wu Research Topics

Disease

31Neoplasms (Cancer)
12/2020 - 01/2000
11Infections
09/2021 - 03/2000
6Stomach Neoplasms (Stomach Cancer)
09/2021 - 05/2000
6Inflammation (Inflammations)
12/2016 - 11/2009
5Body Weight (Weight, Body)
05/2020 - 06/2008
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2019 - 11/2010
5Melanoma (Melanoma, Malignant)
04/2015 - 04/2001
5Carcinoma (Carcinomatosis)
04/2014 - 01/2000
4Neoplasm Metastasis (Metastasis)
01/2022 - 04/2000
4Alzheimer Disease (Alzheimer's Disease)
12/2020 - 11/2000
4Arthritis (Polyarthritis)
11/2018 - 12/2001
4Hypoxia (Hypoxemia)
10/2017 - 03/2012
4Head and Neck Neoplasms (Head and Neck Cancer)
06/2012 - 01/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2014
3Breast Neoplasms (Breast Cancer)
01/2020 - 03/2014
3Myocardial Infarction
02/2019 - 10/2017
3Parkinson Disease (Parkinson's Disease)
01/2019 - 12/2001
3Hypertension (High Blood Pressure)
07/2018 - 05/2001
3Ischemia
09/2015 - 12/2000
3Asthma (Bronchial Asthma)
01/2011 - 01/2009
2Insulin Resistance
07/2022 - 02/2015
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2022 - 06/2001
2Osteoporosis
02/2022 - 08/2010
2Lung Injury
02/2022 - 10/2015
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 12/2021
2Graves Ophthalmopathy
02/2021 - 11/2020
2Lung Neoplasms (Lung Cancer)
01/2021 - 11/2014
2Wounds and Injuries (Trauma)
03/2020 - 10/2019
2Rectal Neoplasms (Rectal Cancer)
07/2019 - 01/2018
2Multiple Myeloma
06/2019 - 10/2014
2Hemorrhage
02/2019 - 05/2017
2Cognitive Dysfunction
01/2019 - 01/2019
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2018 - 06/2010
2Tuberculosis (Tuberculoses)
06/2018 - 10/2016
2Pleural Effusion (Pleural Effusions)
06/2018 - 09/2015
2Leukemia
01/2018 - 03/2012
2Pain (Aches)
01/2018 - 09/2011
2Nausea
11/2017 - 10/2016
2Poisoning
05/2017 - 10/2000
2Liver Cirrhosis (Hepatic Cirrhosis)
05/2017 - 03/2011
2Type 2 Diabetes Mellitus (MODY)
07/2015 - 02/2015
2Brain Neoplasms (Brain Tumor)
04/2015 - 08/2014
2Glioblastoma (Glioblastoma Multiforme)
04/2015 - 08/2014

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
06/2022 - 09/2000
9Peptides (Polypeptides)IBA
12/2020 - 09/2000
8Pharmaceutical PreparationsIBA
09/2021 - 06/2008
7Biological ProductsIBA
12/2021 - 09/2000
6EnzymesIBA
02/2022 - 07/2005
6DNA (Deoxyribonucleic Acid)IBA
01/2020 - 12/2000
5Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2014
5CytokinesIBA
02/2022 - 10/2009
5Phosphotransferases (Kinase)IBA
11/2013 - 04/2001
5Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2001 - 04/2000
4Anti-Bacterial Agents (Antibiotics)IBA
08/2022 - 09/2000
4Messenger RNA (mRNA)IBA
01/2020 - 11/2009
4CollagenIBA
11/2018 - 10/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2017 - 10/2008
3Oxygen (Dioxygen)IBA
10/2019 - 05/2011
3Blood Glucose (Blood Sugar)IBA
07/2018 - 01/2012
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 01/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2017 - 10/2005
3MicroRNAs (MicroRNA)IBA
11/2016 - 07/2015
3Small Interfering RNA (siRNA)IBA
09/2015 - 10/2005
2salicylhydroxamic acid (SHAM)IBA
06/2022 - 09/2015
2Troleandomycin (TAO)FDA Link
02/2021 - 11/2020
2GlucocorticoidsIBA
02/2021 - 01/2014
2Immune Checkpoint InhibitorsIBA
01/2021 - 12/2020
2Amyloid (Amyloid Fibrils)IBA
12/2020 - 09/2015
2Hormones (Hormone)IBA
11/2020 - 05/2020
2InterferonsIBA
01/2020 - 04/2001
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 12/2001
2Interleukin-17 (Interleukin 17)IBA
01/2020 - 09/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2019 - 12/2001
2Bortezomib (Velcade)FDA Link
06/2019 - 07/2013
2Triglycerides (Triacylglycerol)IBA
07/2018 - 01/2012
2CholesterolIBA
07/2018 - 01/2012
2Chimeric Antigen ReceptorsIBA
01/2018 - 01/2018
2Therapeutic UsesIBA
01/2018 - 05/2017
2Peptide Hydrolases (Proteases)FDA Link
01/2017 - 04/2001
2Interleukin-13IBA
12/2016 - 11/2009
2Antiviral Agents (Antivirals)IBA
12/2016 - 04/2001
2ErbB Receptors (EGF Receptor)IBA
09/2016 - 08/2014
2AntibodiesIBA
09/2016 - 08/2013
2icariinIBA
09/2015 - 10/2010
2Insulin (Novolin)FDA Link
02/2015 - 01/2012
2LipidsIBA
02/2015 - 01/2012
2CalciumIBA
10/2014 - 08/2010
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2014 - 12/2013
2Carrier Proteins (Binding Protein)IBA
05/2014 - 11/2013
2Paclitaxel (Taxol)FDA LinkGeneric
04/2014 - 03/2000

Therapy/Procedure

21Therapeutics
08/2022 - 04/2000
7Drug Therapy (Chemotherapy)
01/2022 - 03/2000
7Radiotherapy
07/2021 - 01/2000
5Hematopoietic Stem Cell Transplantation
01/2022 - 07/2013
3Neoadjuvant Therapy
08/2020 - 01/2018
3Transplantation
03/2019 - 06/2014
2Aftercare (After-Treatment)
03/2022 - 10/2019
2Decompression
11/2021 - 09/2011
2Stents
02/2019 - 10/2016
2Conservative Treatment
07/2018 - 12/2015